This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
Apple Gives Stocks a Boost, UPS & Airlines Raise Prices

U.S. markets started Tuesday's trading day higher on the back of positive earnings results.

China's Economy Grows at Slowest Pace in Five Years, Jobs Strong

China's economic growth waned to a five-year low of 7.3 percent last quarter, raising concerns of a spillover effect on the global economy.

General Motors' Recalls Hamper Stock with Rivals Knocking

General Motors' shares have had a rough go of 2014, especially factoring in the last month.

Coca-Cola, Verizon Line up for Earnings Parade, Cramer's Bank Pick

After seeing surprising mega-misses from both Netflix and IBM, market watchers will be keeping a keen eye on today's numbers from Verizon as well as Coca-Cola Co.

What to Watch on Wall Street for Tuesday, October 21st 2014

Tuesday, October 21st is another busy day for quarterly reports as Coca-Cola, McDonald's, Harley-Davidson and Yahoo! report Q3 results.

Real Money Previews

Cramer: Buy Small Oil Companies on This Next Leg Down

Big oil should start buying smaller oil.

Real Money's Kate Stalter: Strategizing Your Retirement Fund

Don't stampede into cash at this stage.

Cramer Reviews His Top 10 List for a Market Recovery: Boxes Checked!

We now have an investable bottom on our hands.

Mad Money Recap

'Mad Money' Lightning Round: I'm Not Going Near Plug Power

Cramer thinks RR Donnelley is a good investment, Fiat is doing quite well and prefers Skyworks Solutions over Sierra Wireless.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

3 Financial Stocks Rising on Big Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

How to Trade the Market's Most-Active Stocks

Here's how to trade some of the most active stocks on the market right now.

4 Huge Stocks on Traders' Radars

Here's how to trade some of the most active stocks on the market today.

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

5 Rocket Stocks to Buy for Earnings Season Gains

These stock shave both short-term gain catalysts and longer-term growth potential.

MainStreet

Airbag Recall and Seat Belt Safety: Are You Driving in Danger?

Certain airbags and seat belts are subject to safety concerns.

Cheap Airfare: What Would You Give Up For a Discount Ticket?

Would you give up legroom for an ultra cheap airfare? How about lavatory access?

Why Parents Need to Know What Heather Mack Is Teaching About Teen Money

The Chicago mother murdered in Indonesia this summer had reportedly tapped into half a million dollars set aside by her late husband for their child.

Will Apple Pay Keep You Safe This Holiday Season Amid Credit Card Breaches?

Yesterday Apple flipped the switch on its new digital payment system Apple Pay. But will it protect you from hacks?

Somehow Halloween Thrives as Other Holiday Shopping Dives

Halloween spending is on the rise yet again as the holiday's appeal continues to shift toward adults and consumers get more satisfaction from spending on themselves.

Biotech

Some Potential Targets for Shire to Buy With $1.6B in Free Money

Shire isn't obligated to spend AbbVie's money, but it's no fun speculating about earned interest. Which drug companies might be takeout targets for Shire?

Ebola Stocks May Be Overpriced as Fundamentals Outweigh Fear

Ebola stocks have soared in recent weeks but a closer look at fundamentals may serve as a reality check for investors playing the story.

First Detailed Look at Celgene Crohn's Disease Pill Impresses

As a pill, Celgene's GED-031 (also known as mongersen) has the potential to become a preferred Crohn's therapy over injectable drugs like Abbvie's top-selling Humira.

Beyond Wall St.

Deal News

Royal Dutch Shell Sets IPO Price Range for U.S. Pipeline Operator

The Anglo-Dutch group expects proceeds of at least $711 million from the sale of almost a third of Shell Midstream Partners.

Cramer: Buy Small Oil Companies on This Next Leg Down

Big oil should start buying smaller oil.

Moment of Truth as Caesars Enters Into Formal Talks With Bank Lenders

Some observers believe the troubled casino operator will try to convince these powerful creditors to become involved in some large decisions.

TheStreetTV
Spin Space

Jim Cramer

Cramer: Buy Small Oil Companies on This Next Leg Down

Big oil should start buying smaller oil.

Herb Greenberg

Greenberg on the Stock Market: Why Investigations No Longer Matter

I can't remember the last time a company got more than a slap on the wrist.

Stephanie Link

Stephanie Link: You Can Still Find Value in this Pullback

Action Alerts PLUS has been buying into it.

Chris Ciaccia

3 Biggest Takeaways From Apple's Strong Earnings Report

Demand for Apple iPhone and Mac is so strong that not only is it surprising Wall Street, it's surprising the most bullish people of all: Apple.

Adam Feuerstein

Some Potential Targets for Shire to Buy With $1.6B in Free Money

Shire isn't obligated to spend AbbVie's money, but it's no fun speculating about earned interest. Which drug companies might be takeout targets for Shire?

Dan Freed

Why Getting a Mortgage Should Soon Be a Little Bit Easier

Bankers and regulators are optimistic they will soon have an agreement intended to ease lenders' concerns.

Ted Reed

Delta to Wall Street: Don't Tell Us How to Run Our Airline

Delta is widely seen as the leading U.S. airline, yet some Wall Street analysts have decided it is adding too much capacity, breaking the mold of 'capacity discipline.'

Leon Lazaroff

Lions Gate Joins Online Video Party in Deal With Tribeca

Lions Gate is joining with Tribeca Enterprises as more TV and movie producers seek to start online subscription services.

Submit an article to us!
DOW 16,481.24 +81.57 0.50%
S&P 500 1,923.24 +19.23 1.01%
NASDAQ 4,368.4370 +52.3630 1.21%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs